Next Science Ltd Market Cap ($30.02 Million)
Market Cap & Net Worth: Next Science Ltd (NXS)
Next Science Ltd market cap. Next Science Ltd (AU:NXS) has a market capitalization of $30.02 Million (AU$42.43 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #23549 globally and #887 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Next Science Ltd's stock price AU$0.15 by its total outstanding shares 292625365 (292.63 Million). Also see Next Science Ltd (NXS) cash conversion ratio for how efficiently the company converts equity into cash flow.
Next Science Ltd Market Cap History (2019–2026)
Next Science Ltd market cap history from 2019 to 2026. Data shows change from $389.26 Million to $30.02 Million (-27.89% CAGR). Check Next Science Ltd stock quote for real-time trading data and today's change.
Next Science Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Next Science Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Next Science Ltd (NXS) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.04x
Next Science Ltd's market cap is 1.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $389.26 Million | $4.11 Million | -$14.52 Million | 94.72x | N/A |
| 2020 | $258.81 Million | $3.44 Million | -$11.91 Million | 75.22x | N/A |
| 2021 | $257.78 Million | $8.95 Million | -$9.35 Million | 28.81x | N/A |
| 2022 | $141.83 Million | $11.71 Million | -$18.30 Million | 12.11x | N/A |
| 2023 | $70.40 Million | $22.18 Million | -$24.51 Million | 3.17x | N/A |
| 2024 | $23.81 Million | $22.82 Million | -$10.59 Million | 1.04x | N/A |
Competitor Companies of NXS by Market Capitalization
Companies near Next Science Ltd in the global market cap rankings as of November 8, 2026. Also see NXS total asset value for a full breakdown of the balance sheet.
Key companies related to Next Science Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Next Science Ltd (2019–2026)
Market capitalization of Next Science Ltd from 2019 to today. Between 2019 and today, Next Science Ltd's market cap moved from $389.26 Million to $ 30.02 Million, with a yearly change of -27.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$30.02 Million | 0.00% |
| 2025 | AU$30.02 Million | +26.09% |
| 2024 | AU$23.81 Million | -66.18% |
| 2023 | AU$70.40 Million | -50.36% |
| 2022 | AU$141.83 Million | -44.98% |
| 2021 | AU$257.78 Million | -0.40% |
| 2020 | AU$258.81 Million | -33.51% |
| 2019 | AU$389.26 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Next Science Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.02 Million USD |
| MoneyControl | $30.02 Million USD |
| MarketWatch | $30.02 Million USD |
| marketcap.company | $30.02 Million USD |
| Reuters | $30.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Next Science Ltd
Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides woun… Read more